Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway

BACKGROUND: Levetiracetam (LEV) is an antiepileptic drug that promotes recovery of neurological function by alleviating inflammatory reactions. However, it is not known whether it can improve secondary brain injury after intracerebral hemorrhage (ICH). The aim of this study was to determine whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jing, Zhou, Han, Lu, Donglin, Wang, Zixuan, Liu, HengJian, Sun, Yuqi, Xu, Jinxiang, Feng, Yugong, Xing, Ang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174898/
https://www.ncbi.nlm.nih.gov/pubmed/32289810
http://dx.doi.org/10.12659/MSM.922741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174898/
https://www.ncbi.nlm.nih.gov/pubmed/32289810
http://dx.doi.org/10.12659/MSM.922741

Ejemplares similares